Alpha 1 Acid Glycoprotein from Cynomolgus Monkey Plasma

Product Description

Alpha 1 Acid Glycoprotein from Cynomolgus Monkey Plasma
Catalog number: B2015376
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 ug
Molecular Weight or Concentration: 55 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Alpha 1 Acid Glycoprotein, Cynomolgus Monkey Plasma
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Riccardi K, Cawley S, Yates PD, Chang C, Funk C, Niosi M, Lin J, Di L. Plasma Protein Binding of Challenging Compounds J Pharm Sci. 2015 Aug;104(8):2627-36.
2: Koyanagi T, Yamaura Y, Yano K, Kim S, Yamazaki H. Age-related pharmacokinetic changes of acetaminophen, antipyrine, diazepam, diphenhydramine, and ofloxacin in male cynomolgus monkeys and beagle dogs Xenobiotica. 2014 Oct;44(10):893-901.
3: Weiss HM, Gatlik E. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs J Pharm Sci. 2014 Feb;103(2):752-9.
4: Smith S, Hoyt J, Whitebread N, Manna J, Peluso M, Faia K, Campbell V, Tremblay M, Nair S, Grogan M, Castro A, Campbell M, Ferguson J, Arsenault B, Nevejans J, Carter B, Lee J, Dunbar J, McGovern K, Read M, Adams J, Constan A, Loewen G, Sydor J, Palombella V, Soglia J. The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway Xenobiotica. 2013 Oct;43(10):875-85.
5: Nagase K, Iwasaki K, Nozaki K, Noda K. Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes J Pharm Pharmacol. 1994 Feb;46(2):113-7.
6: Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys Arzneimittelforschung. 1993 Oct;43(10):1084-94.
7: Kretz O, Weiss HM, Schumacher MM, Gross G. In vitro blood distribution and plasma protein binding of the tyrosine kinase inhibitor imatinib and its active metabolite, CGP74588, in rat, mouse, dog, monkey, healthy humans and patients with acute lymphatic leukaemia Br J Clin Pharmacol. 2004 Aug;58(2):212-6.
8: Wargin W, Thomas H, Clohs L, St-Louis C, Ejskjaer N, Gutierrez M, Shaughnessy L, Kosutic G. Contribution of protein binding to the pharmacokinetics of the ghrelin receptor agonist TZP-101 in healthy volunteers and adults with symptomatic gastroparesis: two randomized, double-blind studies and a binding profile study Clin Drug Investig. 2009;29(6):409-18.
9: Nonaka K, Tsujioka T, Tougou K, Mukai H. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys Arzneimittelforschung. 2003;53(9):612-20.
10: Hannothiaux MH, Scharfman A, Leger D, Van Brussel E, Lafitte JJ, Roussel P. Identification of plasma proteins contained in bronchoalveolar fluid from Macacus cynomolgus Comp Biochem Physiol B. 1989;92(4):645-50.

Products Related to Alpha 1 Acid Glycoprotein from Cynomolgus Monkey Plasma can be found at Proteins